Elena Prokupets, Director at C4 Therapeutics, Inc. (CCCC), sold 10,530 shares at $50.00 ($527K) on 2021-09-10, disclosed to the SEC on 2021-09-14.
Open-market sale of $527k CCCC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 1,230 | $62K | 11.7% |
| 2 | $50.01 | 1,320 | $66K | 12.5% |
| 3 | $50.01 | 1,320 | $66K | 12.5% |
| 4 | $50.07 | 3,330 | $167K | 31.6% |
| 5 | $50.07 | 3,330 | $167K | 31.6% |
| Total | $50.05 avg | 10,530 |
| $527K |
| 100% |
| Filing → |
| CCCC | SELL | 2021-09-21 | $2.1M | — | Filing → |
| CCCC | SELL | 2021-09-16 | $6.4M | — | Filing → |
| CCCC | SELL | 2021-08-05 | $1.3M | — | Filing → |